Noel Duplantier, MD
Obstetrics & Gynecology · Bay Saint Louis, MSNPI 1811061831
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (50.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 65.9% of it on its own, with 34 other manufacturers making up the rest. Reporting peaked in 2023 at $6,890 and has fallen 90.4% since, to $660 in 2025. Among obstetrics & gynecology clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 186 payments — averaging $50.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$6K
- AbbVie$730
- Astellas Pharma US Inc$323
- Mayne Pharma Commercial LLC$295
- Amgen$177
- Exeltis, USA Inc.$175
- plus $2K from 29 others
Across 9 payments — averaging $30,847 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$206K
- Genbiopro, Inc.$34K
- GSK$21K
- Pfizer$17K
What the payments were for
- Travel & lodging$1,57717%
- Food & beverage$3,11133%
- Education$4,77450%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 19 | $6,235 |
| AbbVie(2 entities) | 50 | $730 |
| Astellas Pharma US Inc | 16 | $323 |
| Mayne Pharma Commercial LLC | 13 | $295 |
| Amgen | 10 | $177 |
| Exeltis, USA Inc. | 9 | $175 |
| Myriad Women's Health, Inc. | 2 | $157 |
| Novo Nordisk | 2 | $137 |
| Channel Medsystems, Inc. | 1 | $123 |
| Sumitomo Pharma America, Inc. | 8 | $122 |
| Daiichi Sankyo Inc. | 6 | $113 |
| Therapeuticsmd, Inc. | 8 | $101 |
| Pfizer | 5 | $92 |
| Organon | 8 | $86 |
| Sage Therapeutics, LLC | 4 | $81 |
| Dysis Medical, Inc. | 1 | $68 |
| Hologic Sales And Service, LLC | 2 | $55 |
| Coopersurgical, Inc. | 1 | $55 |
| Abbott | 2 | $34 |
| Mylan Pharmaceuticals Inc. | 2 | $30 |
| Merck | 2 | $28 |
| BD | 2 | $27 |
| LSI Solutions Inc | 1 | $26 |
| Supernus Pharmaceuticals, Inc. | 1 | $25 |
| Millicent US Inc | 1 | $24 |
| Vertex | 1 | $20 |
| Smith+Nephew | 1 | $18 |
| Lilly USA, LLC | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
| Alfasigma USA, Inc. | 1 | $15 |
| Genentech USA, Inc. | 1 | $14 |
| Scynexis, Inc. | 1 | $14 |
| AMAG Pharmaceuticals, Inc. | 1 | $12 |
| Evofem Biosciences, Inc. | 1 | $12 |
| Meditrina | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$4,500
- Da Vinci Surgical System$1,520
- Ozempic$124
- CERENE CRYOTHERAPY DEVICE$123
- myRisk$113
- NEXTSTELLIS$104
How this compares
$9,462 in reported general payments places this provider in the 95th percentile of 318 obstetrics & gynecology providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 13 | $8,399 |
| Estradiol | 115 | $4,078 |
| ProgesteroneProgesterone, Micronized | 52 | $1,495 |
| ClimaraEstradiol | 12 | $864 |
| Clobetasol Propionate | 25 | $703 |
| Tolterodine Tartrate ErTolterodine Tartrate | 20 | $625 |
| Terconazole | 14 | $492 |
| Metronidazole | 27 | $488 |
| ValacyclovirValacyclovir Hcl | 14 | $386 |
| Famciclovir | 11 | $314 |
| Ketoconazole | 38 | $289 |
| Oxybutynin Chloride ErOxybutynin Chloride | 14 | $262 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 15 | $243 |
| Bupropion XlBupropion Hcl | 17 | $235 |
| Fluconazole | 25 | $91 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $323 | $8,39913 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 318 obstetrics & gynecology providers in Mississippi.
Other obstetrics & gynecology in Bay Saint Louis
- Robert DesantisEllisville$212K
- Lori FultonJackson$102K
- Sheila BouldinJackson$56K
- Melissa BarnettTupelo$50K
- Ahmet BedestaniFlowood$41K
- Stacey KreherBay St. Louis$40K
- Joseph McGeheeTupelo$35K
- Elizabeth TarsiTupelo$21K
- Charlene CollierRidgeland$20K
- Douglas TurnerAmory$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.